Department of Reproductive Center, Zhoushan Maternity and Child Healthcare Hospital.
Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University.
Biosci Trends. 2018;12(5):463-469. doi: 10.5582/bst.2018.01164.
To compare the clinical outcomes of intrauterine insemination (IUI) with or without ovulation induction (OI), IUI cycles from January 2008 to December 2017 in Zhoushan Maternity and Child Healthcare Hospital were included, consisting of 455 natural cycles and 536 OI cycles. The overall clinical pregnancy rate did not differ between the two groups (P > 0.05). Stratified by OI medications such as clomiphene (CC), human menopausal gonadotropin (HMG) and follicle stimulating hormone (FSH), the pregnancy rates in HMG, CC, CC+HMG, and FSH/FSH+HMG groups were 11.70%, 13.58%, 15.95%, and 13.46%, respectively, but the difference was not significant compared with natural cycles (P > 0.05). Stratified by infertility etiology, the pregnancy rate was significantly higher in stimulated cycles than natural cycles with ovulation disorders (P < 0.01) and unexplained factors (P < 0.01) while it was significantly lower regarding cervical factors (P < 0.01), endometriosis (P < 0.05), male factor (P < 0.01) and other female factors. There was no strong difference of pregnancy rate for biparental causes (P > 0.05). Stratified by age category, women over 35 had higher pregnancy rate in stimulated cycles compared with natural cycles (18.75 vs. 12.24%; P < 0.05), while women under 35 had no significant difference of pregnancy rate between the two groups (13.65 vs 13.05%; P > 0.05). However, there was no significant difference between each ovarian stimulation group and natural cycle group regardless of the infertility causes or age categories. To conclude, IUI-OI could achieve a higher overall pregnancy rate for women over 35 and infertile patients with ovulation disorders and unexplained factors.
为了比较有或无排卵诱导(OI)的宫腔内人工授精(IUI)的临床结局,纳入了 2008 年 1 月至 2017 年 12 月在舟山妇幼保健院进行的 IUI 周期,包括 455 个自然周期和 536 个 OI 周期。两组的总临床妊娠率无差异(P>0.05)。按 OI 药物(如氯米芬(CC)、人绝经期促性腺激素(HMG)和卵泡刺激素(FSH))分层,HMG、CC、CC+HMG 和 FSH/FSH+HMG 组的妊娠率分别为 11.70%、13.58%、15.95%和 13.46%,但与自然周期相比差异无统计学意义(P>0.05)。按不孕病因分层,排卵障碍(P<0.01)和不明原因(P<0.01)的刺激周期妊娠率明显高于自然周期,而宫颈因素(P<0.01)、子宫内膜异位症(P<0.05)、男性因素(P<0.01)和其他女性因素的刺激周期妊娠率明显低于自然周期。对于双亲原因,妊娠率无明显差异(P>0.05)。按年龄分类,35 岁以上的女性刺激周期妊娠率高于自然周期(18.75%比 12.24%;P<0.05),而 35 岁以下的女性两组妊娠率无差异(13.65%比 13.05%;P>0.05)。然而,无论不孕病因或年龄分类如何,每个卵巢刺激组与自然周期组之间均无显著差异。综上所述,IUI-OI 可提高 35 岁以上女性和排卵障碍及不明原因不孕患者的总妊娠率。